23 November 2017
News and Views
Links and Services
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab, reports the latest issue of Gut.
Serum infliximab trough levels correlate with efficacy; dose escalation is often beneficial in pa
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors